0
New
New
2023
Skin Antiseptic Market

Skin Antiseptic Market

by Type (Alcohol, Chlorhexidine, Iodine, Others), by Form (Solutions, Cream, Swab Sticks, Others), by Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A12682
Mar 2023 | Pages: 300
Tables: 131
Charts: 68
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Skin Antiseptic Market Research, 2031

The global skin antiseptic market size was valued at $1,484.28 million in 2021 and is estimated to reach $3,060.81 million by 2031, growing at a CAGR of 7.5% from 2022 to 2031. Skin antiseptics are substances used to kill or inhibit the growth of microorganisms on the skin surface. These agents are used to prepare the skin before medical procedures to prevent infections. Skin antiseptics are essential for maintaining a sterile environment during surgical procedures and other invasive medical procedures.

The primary objective of using skin antiseptics is to reduce the number of microorganisms on the skin surface , as they can cause infections if entered in the body through a broken skin or invasion done for surgical procedure. By using skin antiseptics, healthcare providers can significantly reduce the risk of infections and their associated complications. Further, skin antiseptics are available in various forms, such as liquids, gels, sprays, and wipes. They contain active ingredients that are effective against a broad range of microorganisms. The most commonly used active ingredients in skin antiseptics include chlorhexidine, povidone-iodine, and alcohol.

The skin antiseptic market was positively impacted during the lockdown period owing to rise in vaccination programs, which increased the demand for skin antiseptics. Moreover, post pandemic, rise in adoption of personal hygiene has shown positive impact on the growth of the market.

Skin Antiseptic Market

“The skin antiseptic market was positively impacted during the lockdown period owing to rise in vaccination programs, which increased the demand for skin antiseptics. Moreover, post pandemic, rise in adoption of personal hygiene has shown positive impact on the growth of the market.”

Market Dynamics

The major factor driving the skin antiseptic market is the higher prevalence of hospital acquired infections (HAIs). These infections are caused by bacteria, viruses, and other microorganisms that patients can contract during their stay in a healthcare facility. HAIs can cause a range of illnesses, from mild to severe, and can even lead to death in some cases. To prevent HAIs, healthcare facilities must maintain high standards of hygiene, which includes the use of skin antiseptics. In addition, skin antiseptics are essential in reducing the risk of infection during invasive procedures such as surgeries and other medical procedures.

Moreover, the global antiseptic industry has witnessed a higher rate of growth due to increased expenditure on healthcare. With the growing healthcare industry, there is an increase in focus on improving the quality of care and reducing the incidence of infections. This is leading to an increased demand for antiseptics, including skin antiseptics.

Furthermore, rise in incidences of sports and road accident injuries is anticipated to drive the skin antiseptic market growth. As such injuries can lead to open wounds, abrasions and lacerations, which accounts to the high risk of infections due to the exposure to the external environment, soil, dust, and debris containing a range of microorganisms. Thus, skin antiseptics play an important role in reducing the risk of infections and promoting wound healing, which is expected to propel the market growth.

E-commerce (electronic commerce) has become a vital tool for small and large businesses globally, due to rise in preference of consumers for online shopping over traditional purchasing methods. Various animations through health apps to educate people regarding infection prevention and usage of wide range of skin antiseptic forms have contributed toward the growth of skin antiseptic market size. The demand for effective infection control solutions is not only limited to developed countries but is also being witnessed in the developing countries, such as China, Brazil, and India, which fuel the growth of the skin antiseptic market share. Moreover, an increase in promotional activities by manufacturers and growth in awareness for proper infection prevention and control among the general population are expected to fuel their adoption during the forecast period.

However, factor such as side effects associated with certain skin antiseptic restrains the growth of skin antiseptic market. In addition, permeability issue and allergic reactions associated with skin antiseptic hampers the growth of skin antiseptic market share. Furthermore, regulations on use of skin antiseptics containing alcohol-based formulations accounts to the minimization of side effects and thus provides lucrative opportunities to key players of the Skin antiseptic market.

The outbreak of COVID-19 disrupted growth in many economies across various domains. The pandemic positively impact the growth of skin antiseptic market. As the use of skin antiseptics was increased during the COVID-19 pandemic owing to prevent the spread of the virus. In addition, skin antiseptics were commonly used in healthcare settings to prevent infections during medical procedures, such as surgeries, and to prevent the spread of infections in hospitals. However, with the emergence of COVID-19, the use of skin antiseptics expanded beyond healthcare settings, thereby positively impacted to growth of market. Furthermore, hand sanitizers containing at least 60% alcohol are the most commonly used skin antiseptics for the disinfection of skin. They are effective in killing most types of viruses and bacteria, including the COVID-19 virus. In addition to hand sanitizers, other skin antiseptics, such as alcohol-based wipes and sprays, are also being used as skin antiseptic. Thus, pandemic positively impacted to growth of market.

Segmental Overview

The skin antiseptic market is segmented into type, form, distribution channel, and region. On the basis of type, the market is categorized into alcohol, chlorhexidine, iodine, and others. On the basis of form, the market is classified into solutions, cream, swab sticks, and others. On the basis of distribution channel, the market is segregated into hospital pharmacies, online providers, and drug stores and retail pharmacies. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Skin Antiseptic Market

By Type

The skin antiseptic market is categorized into alcohol, chlorhexidine, iodine and others. The alcohol segment accounted for the largest share in terms of revenue in 2021 and is expected to witness highest CAGR during the forecast period, owing to increased usage of alcohol skin antiseptics during surgical procedures and rise in number of key players offering alcohol-based skin antiseptic. In addition, alcohol-based skin antiseptic are effective against wide range of microbes, thereby are highly adopted as compared to other skin antiseptic.

Skin Antiseptic Market

By Form

The skin antiseptic market is categorized into the market is categorized into solutions, cream, swab sticks, and others. The solution segment accounted for largest share in terms of revenue in 2021 owing to wide availability of antiseptic solution and increase in adoption of antiseptic solutions in pre-operation and pre-injection skin preparation. The others segment is projected to register highest CAGR during forecast period owing to rise in adoption of other form of antiseptic such as wipe skin antiseptic during surgeries and number of key players offering wipe and soap form of skin antiseptic.

Skin Antiseptic Market

By Distribution Channel

The skin antiseptic industry is categorized into hospital pharmacies, drug stores and retail pharmacies and online providers. The drug stores and retail pharmacies segment occupied highest share in 2021 and is expected to remain dominant during forecast period owing to accessibility of retail pharmacies everywhere and large chain of distribution networks. The online providers segment is projected to register highest CAGR during forecast period owing to rise in popularity of online pharmacy and number of users preferring online pharmacies.

Skin Antiseptic Market

By Region

The skin antiseptic industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for largest share in terms of revenue in 2021 and is expected to remain dominant during the forecast period owing to rise in number of surgical procedures and presence of major players offering skin antiseptic. In addition, rising prevalence of hospital acquired infections (HAIs) such as central line-associated bloodstream infections (CLABSIs) are expected to drive the market. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in implementation of infection control measures, rise in number of surgical site infections and availability of wide range of skin antiseptic products, thereby driving the growth of market during the forecast period.

Presence of several major players, such as Cardinal Health Inc., Becton, Dickinson and Company, 3M Company, and B. Braun SE. and advancement in manufacturing technology for development of effective form of skin antiseptics in the region is expected to drive the growth of market. Furthermore, the presence of well-established healthcare infrastructure, and the rise in adoption rate of wide range of dosage forms such as wipes, swabstick, spary, and gels are expected to drive the market growth. Furthermore, various product approval and contract agreements as key strategies adopted by the key players in this region further boost the growth of the market.

Asia-Pacific is expected to grow at the highest rate during the forecast period. The market growth in this region is attributable to the presence of key players in the region. Moreover, the rise in incidences of road accidents results in demand for primary care such as disinfecting the wounds by using skin antiseptics, which is expected to drive the growth of the market. For instance, according to a report by the Ministry of Road Transport and Highways – India 2021, there was a 12.6% rise in road accidents as compared to 2020. Thus, rise in incidences of accidental injuries is expected to drive the market growth.

Further, many countries such as India, Australia and UK, the increasing government initiative in awareness and guidelines regarding infection prevention and control is anticipated to drive the market growth. Asia-Pacific offers profitable opportunities for key players operating in the Skin antiseptic market, thereby registering the fastest growth rate during the skin antiseptic market forecast, owing to the growing infrastructure of industries, rising in demand of skin antiseptics to reduce the risk of infections, as well as well-established presence of domestic companies in the region. In addition, the rise in contract manufacturing organizations within the region provides great opportunity for new entrants in this region.

Competition Analysis

Competitive analysis and profiles of the major players in the Skin antiseptic market, such as Cardinal Health Inc., Becton, Dickinson and Company, B. Braun SE, 3M Company, Ecolab, Mölnlycke Health Care AB, Xttrium Laboratories, SIRMAXO CHEMICALS PVT.LTD., Schülke & Mayr GmbH, PDI, Inc. are provided in this report. Major players have adopted product approval, launch, business expansion, and acquisition as key developmental strategies to improve the product portfolio of the Skin antiseptic market.

Recent Product Approval in Skin antiseptic market

  • In April 2019, BD (Becton, Dickinson and Company), a leading global medical technology company, announced that it received U.S. Food and Drug Administration (FDA) approval for BD ChloraPrep skin preparation with sterile solution, the only fully sterile chlorhexidine gluconate (CHG) antiseptic skin preparation commercially available in the U.S.

Product Launch in Skin Antiseptic Market

  • In July 2020, BD (Becton, Dickinson and Company) a leading global medical technology company, announced the launch of BD PurPrep patient preoperative skin preparation with sterile solution, the first and only fully sterile povidone-iodine plus isopropyl alcohol single-use antiseptic skin preparation commercially available in the United States.

Business Expansion in Skin Antiseptic Market

  • In March 2019- PDI, a leader in infection prevention products and solutions for its customers, officially opened the doors to its new global headquarters in Bergen County, NJ. The new headquarters represents the continued investment in PDI’s products and customer solutions, and its dedication to R&D.

Partnership in Skin Antiseptic Market

  • In January 2022, PDI announced a strategic partnership with the Association for Professionals with goal to advance the science and practice of infection prevention and control in healthcare facilities

Acquisition in Skin Antiseptic Market

  • In September 2022- Schülke Group, a leading global provider in the fields of infection prevention and hygiene solutions in healthcare, announced the acquisition of the Spanish company Vesismin Health based in Barcelona specialized in hospital infection control.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the skin antiseptic market analysis from 2021 to 2031 to identify the prevailing skin antiseptic market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the skin antiseptic market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global skin antiseptic market trends, key players, market segments, application areas, and market growth strategies.

Skin Antiseptic Market Report Highlights

Aspects Details
Market Size By 2031 USD 3.1 billion
Growth Rate CAGR of 7.5%
Forecast period 2021 - 2031
Report Pages 300
By Type
  • Alcohol
  • Chlorhexidine
  • Iodine
  • Others
By Form
  • Solutions
  • Cream
  • Swab Sticks
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Online Providers
  • Drug Stores and Retail Pharmacies
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Ecolab Inc., Schülke & Mayr GmbH, B. Braun SE, 3M Company, Cardinal Health Inc., Becton, Dickinson and Company, PDI, Inc., Molnlycke Health Care AB, Xttrium Laboratories, SIRMAXO CHEMICALS PVT.LTD.

Analyst Review

This section provides various opinions of top-level CXOs in the global skin antiseptic market. According to the insights of CXOs, increase in demand for skin antiseptic and rise in number of hospitals acquired infection (HAIs) are expected to offer profitable opportunities for the expansion of the market. In addition, favorable government initiatives and higher spending for infection control have piqued the interest of several companies to develop skin antiseptic.

CXOs further added that increase in number of key players offering various forms of skin antiseptic such as wipes, swabs, and antiseptic soaps are expected to boost the growth of market. In addition, rise in number of surgeries carried out every year across the globe results in demand for skin antiseptic, thus driving the growth of market.

Furthermore, North America accounted for the largest share in terms of revenue in 2021 and is expected to remain dominant during the forecast period owing to rise in number of surgical procedures and presence of major players offering skin antiseptic. In addition, increase in prevalence of hospital acquired infections (HAIs) such as central line-associated bloodstream infections (CLABSIs) are expected to drive the market. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in implementation of infection control measures, surge in number of surgical site infections, and availability of wide range of skin antiseptic products, thereby driving the growth of market during the forecast period.

 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Bargaining power of suppliers

      • 3.3.2. Bargaining power of buyers

      • 3.3.3. Threat of substitutes

      • 3.3.4. Threat of new entrants

      • 3.3.5. Intensity of rivalry

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Increase in prevalence of hospital – acquired infections (HAIs)
        • 3.4.1.2. Rise in number of surgeries

      • 3.4.2. Restraints

        • 3.4.2.1. Side effects and adverse reactions

      • 3.4.3. Opportunities

        • 3.4.3.1. Growth in opportunities in emerging markets

    • 3.5. COVID-19 Impact Analysis on the market

  • CHAPTER 4: SKIN ANTISEPTIC MARKET, BY TYPE

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Alcohol

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Chlorhexidine

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

    • 4.4. Iodine

      • 4.4.1. Key market trends, growth factors and opportunities

      • 4.4.2. Market size and forecast, by region

      • 4.4.3. Market share analysis by country

    • 4.5. Others

      • 4.5.1. Key market trends, growth factors and opportunities

      • 4.5.2. Market size and forecast, by region

      • 4.5.3. Market share analysis by country

  • CHAPTER 5: SKIN ANTISEPTIC MARKET, BY FORM

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Solutions

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Cream

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

    • 5.4. Swab Sticks

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis by country

    • 5.5. Others

      • 5.5.1. Key market trends, growth factors and opportunities

      • 5.5.2. Market size and forecast, by region

      • 5.5.3. Market share analysis by country

  • CHAPTER 6: SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Hospital Pharmacies

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Online Providers

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

    • 6.4. Drug Stores and Retail Pharmacies

      • 6.4.1. Key market trends, growth factors and opportunities

      • 6.4.2. Market size and forecast, by region

      • 6.4.3. Market share analysis by country

  • CHAPTER 7: SKIN ANTISEPTIC MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key trends and opportunities

      • 7.2.2. Market size and forecast, by Type

      • 7.2.3. Market size and forecast, by Form

      • 7.2.4. Market size and forecast, by Distribution Channel

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Key market trends, growth factors and opportunities
          • 7.2.5.1.2. Market size and forecast, by Type
          • 7.2.5.1.3. Market size and forecast, by Form
          • 7.2.5.1.4. Market size and forecast, by Distribution Channel
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Key market trends, growth factors and opportunities
          • 7.2.5.2.2. Market size and forecast, by Type
          • 7.2.5.2.3. Market size and forecast, by Form
          • 7.2.5.2.4. Market size and forecast, by Distribution Channel
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Key market trends, growth factors and opportunities
          • 7.2.5.3.2. Market size and forecast, by Type
          • 7.2.5.3.3. Market size and forecast, by Form
          • 7.2.5.3.4. Market size and forecast, by Distribution Channel
    • 7.3. Europe

      • 7.3.1. Key trends and opportunities

      • 7.3.2. Market size and forecast, by Type

      • 7.3.3. Market size and forecast, by Form

      • 7.3.4. Market size and forecast, by Distribution Channel

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Key market trends, growth factors and opportunities
          • 7.3.5.1.2. Market size and forecast, by Type
          • 7.3.5.1.3. Market size and forecast, by Form
          • 7.3.5.1.4. Market size and forecast, by Distribution Channel
        • 7.3.5.2. France
          • 7.3.5.2.1. Key market trends, growth factors and opportunities
          • 7.3.5.2.2. Market size and forecast, by Type
          • 7.3.5.2.3. Market size and forecast, by Form
          • 7.3.5.2.4. Market size and forecast, by Distribution Channel
        • 7.3.5.3. UK
          • 7.3.5.3.1. Key market trends, growth factors and opportunities
          • 7.3.5.3.2. Market size and forecast, by Type
          • 7.3.5.3.3. Market size and forecast, by Form
          • 7.3.5.3.4. Market size and forecast, by Distribution Channel
        • 7.3.5.4. Italy
          • 7.3.5.4.1. Key market trends, growth factors and opportunities
          • 7.3.5.4.2. Market size and forecast, by Type
          • 7.3.5.4.3. Market size and forecast, by Form
          • 7.3.5.4.4. Market size and forecast, by Distribution Channel
        • 7.3.5.5. Spain
          • 7.3.5.5.1. Key market trends, growth factors and opportunities
          • 7.3.5.5.2. Market size and forecast, by Type
          • 7.3.5.5.3. Market size and forecast, by Form
          • 7.3.5.5.4. Market size and forecast, by Distribution Channel
        • 7.3.5.6. Rest of Europe
          • 7.3.5.6.1. Key market trends, growth factors and opportunities
          • 7.3.5.6.2. Market size and forecast, by Type
          • 7.3.5.6.3. Market size and forecast, by Form
          • 7.3.5.6.4. Market size and forecast, by Distribution Channel
    • 7.4. Asia-Pacific

      • 7.4.1. Key trends and opportunities

      • 7.4.2. Market size and forecast, by Type

      • 7.4.3. Market size and forecast, by Form

      • 7.4.4. Market size and forecast, by Distribution Channel

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. Japan
          • 7.4.5.1.1. Key market trends, growth factors and opportunities
          • 7.4.5.1.2. Market size and forecast, by Type
          • 7.4.5.1.3. Market size and forecast, by Form
          • 7.4.5.1.4. Market size and forecast, by Distribution Channel
        • 7.4.5.2. China
          • 7.4.5.2.1. Key market trends, growth factors and opportunities
          • 7.4.5.2.2. Market size and forecast, by Type
          • 7.4.5.2.3. Market size and forecast, by Form
          • 7.4.5.2.4. Market size and forecast, by Distribution Channel
        • 7.4.5.3. Australia
          • 7.4.5.3.1. Key market trends, growth factors and opportunities
          • 7.4.5.3.2. Market size and forecast, by Type
          • 7.4.5.3.3. Market size and forecast, by Form
          • 7.4.5.3.4. Market size and forecast, by Distribution Channel
        • 7.4.5.4. India
          • 7.4.5.4.1. Key market trends, growth factors and opportunities
          • 7.4.5.4.2. Market size and forecast, by Type
          • 7.4.5.4.3. Market size and forecast, by Form
          • 7.4.5.4.4. Market size and forecast, by Distribution Channel
        • 7.4.5.5. South Korea
          • 7.4.5.5.1. Key market trends, growth factors and opportunities
          • 7.4.5.5.2. Market size and forecast, by Type
          • 7.4.5.5.3. Market size and forecast, by Form
          • 7.4.5.5.4. Market size and forecast, by Distribution Channel
        • 7.4.5.6. Rest of Asia-Pacific
          • 7.4.5.6.1. Key market trends, growth factors and opportunities
          • 7.4.5.6.2. Market size and forecast, by Type
          • 7.4.5.6.3. Market size and forecast, by Form
          • 7.4.5.6.4. Market size and forecast, by Distribution Channel
    • 7.5. LAMEA

      • 7.5.1. Key trends and opportunities

      • 7.5.2. Market size and forecast, by Type

      • 7.5.3. Market size and forecast, by Form

      • 7.5.4. Market size and forecast, by Distribution Channel

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Brazil
          • 7.5.5.1.1. Key market trends, growth factors and opportunities
          • 7.5.5.1.2. Market size and forecast, by Type
          • 7.5.5.1.3. Market size and forecast, by Form
          • 7.5.5.1.4. Market size and forecast, by Distribution Channel
        • 7.5.5.2. Saudi Arabia
          • 7.5.5.2.1. Key market trends, growth factors and opportunities
          • 7.5.5.2.2. Market size and forecast, by Type
          • 7.5.5.2.3. Market size and forecast, by Form
          • 7.5.5.2.4. Market size and forecast, by Distribution Channel
        • 7.5.5.3. South Africa
          • 7.5.5.3.1. Key market trends, growth factors and opportunities
          • 7.5.5.3.2. Market size and forecast, by Type
          • 7.5.5.3.3. Market size and forecast, by Form
          • 7.5.5.3.4. Market size and forecast, by Distribution Channel
        • 7.5.5.4. Rest of LAMEA
          • 7.5.5.4.1. Key market trends, growth factors and opportunities
          • 7.5.5.4.2. Market size and forecast, by Type
          • 7.5.5.4.3. Market size and forecast, by Form
          • 7.5.5.4.4. Market size and forecast, by Distribution Channel
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top player positioning, 2021

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Cardinal Health Inc.

      • 9.1.1. Company overview

      • 9.1.2. Key Executives

      • 9.1.3. Company snapshot

      • 9.1.4. Operating business segments

      • 9.1.5. Product portfolio

      • 9.1.6. Business performance

    • 9.2. Becton, Dickinson and Company

      • 9.2.1. Company overview

      • 9.2.2. Key Executives

      • 9.2.3. Company snapshot

      • 9.2.4. Operating business segments

      • 9.2.5. Product portfolio

      • 9.2.6. Business performance

      • 9.2.7. Key strategic moves and developments

    • 9.3. B. Braun SE

      • 9.3.1. Company overview

      • 9.3.2. Key Executives

      • 9.3.3. Company snapshot

      • 9.3.4. Operating business segments

      • 9.3.5. Product portfolio

      • 9.3.6. Business performance

    • 9.4. 3M Company

      • 9.4.1. Company overview

      • 9.4.2. Key Executives

      • 9.4.3. Company snapshot

      • 9.4.4. Operating business segments

      • 9.4.5. Product portfolio

      • 9.4.6. Business performance

    • 9.5. Ecolab Inc.

      • 9.5.1. Company overview

      • 9.5.2. Key Executives

      • 9.5.3. Company snapshot

      • 9.5.4. Operating business segments

      • 9.5.5. Product portfolio

      • 9.5.6. Business performance

    • 9.6. Molnlycke Health Care AB

      • 9.6.1. Company overview

      • 9.6.2. Key Executives

      • 9.6.3. Company snapshot

      • 9.6.4. Operating business segments

      • 9.6.5. Product portfolio

      • 9.6.6. Business performance

    • 9.7. Xttrium Laboratories

      • 9.7.1. Company overview

      • 9.7.2. Key Executives

      • 9.7.3. Company snapshot

      • 9.7.4. Operating business segments

      • 9.7.5. Product portfolio

    • 9.8. SIRMAXO CHEMICALS PVT.LTD.

      • 9.8.1. Company overview

      • 9.8.2. Key Executives

      • 9.8.3. Company snapshot

      • 9.8.4. Operating business segments

      • 9.8.5. Product portfolio

    • 9.9. Schülke & Mayr GmbH

      • 9.9.1. Company overview

      • 9.9.2. Key Executives

      • 9.9.3. Company snapshot

      • 9.9.4. Operating business segments

      • 9.9.5. Product portfolio

      • 9.9.6. Key strategic moves and developments

    • 9.10. PDI, Inc.

      • 9.10.1. Company overview

      • 9.10.2. Key Executives

      • 9.10.3. Company snapshot

      • 9.10.4. Operating business segments

      • 9.10.5. Product portfolio

      • 9.10.6. Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 01. GLOBAL SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 02. SKIN ANTISEPTIC MARKET FOR ALCOHOL, BY REGION, 2021-2031 ($MILLION)
    TABLE 03. SKIN ANTISEPTIC MARKET FOR CHLORHEXIDINE, BY REGION, 2021-2031 ($MILLION)
    TABLE 04. SKIN ANTISEPTIC MARKET FOR IODINE, BY REGION, 2021-2031 ($MILLION)
    TABLE 05. SKIN ANTISEPTIC MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 06. GLOBAL SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 07. SKIN ANTISEPTIC MARKET FOR SOLUTIONS, BY REGION, 2021-2031 ($MILLION)
    TABLE 08. SKIN ANTISEPTIC MARKET FOR CREAM, BY REGION, 2021-2031 ($MILLION)
    TABLE 09. SKIN ANTISEPTIC MARKET FOR SWAB STICKS, BY REGION, 2021-2031 ($MILLION)
    TABLE 10. SKIN ANTISEPTIC MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 11. GLOBAL SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 12. SKIN ANTISEPTIC MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
    TABLE 13. SKIN ANTISEPTIC MARKET FOR ONLINE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 14. SKIN ANTISEPTIC MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
    TABLE 15. SKIN ANTISEPTIC MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 16. NORTH AMERICA SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 17. NORTH AMERICA SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 18. NORTH AMERICA SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 19. NORTH AMERICA SKIN ANTISEPTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 20. U.S. SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 21. U.S. SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 22. U.S. SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 23. CANADA SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 24. CANADA SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 25. CANADA SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 26. MEXICO SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 27. MEXICO SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 28. MEXICO SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 29. EUROPE SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 30. EUROPE SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 31. EUROPE SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 32. EUROPE SKIN ANTISEPTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 33. GERMANY SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 34. GERMANY SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 35. GERMANY SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 36. FRANCE SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 37. FRANCE SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 38. FRANCE SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 39. UK SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 40. UK SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 41. UK SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 42. ITALY SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 43. ITALY SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 44. ITALY SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 45. SPAIN SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 46. SPAIN SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 47. SPAIN SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 48. REST OF EUROPE SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 49. REST OF EUROPE SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 50. REST OF EUROPE SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 51. ASIA-PACIFIC SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 52. ASIA-PACIFIC SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 53. ASIA-PACIFIC SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 54. ASIA-PACIFIC SKIN ANTISEPTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 55. JAPAN SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 56. JAPAN SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 57. JAPAN SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 58. CHINA SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 59. CHINA SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 60. CHINA SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 61. AUSTRALIA SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 62. AUSTRALIA SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 63. AUSTRALIA SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 64. INDIA SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 65. INDIA SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 66. INDIA SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 67. SOUTH KOREA SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 68. SOUTH KOREA SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 69. SOUTH KOREA SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 70. REST OF ASIA-PACIFIC SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 71. REST OF ASIA-PACIFIC SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 72. REST OF ASIA-PACIFIC SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 73. LAMEA SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 74. LAMEA SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 75. LAMEA SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 76. LAMEA SKIN ANTISEPTIC MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 77. BRAZIL SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 78. BRAZIL SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 79. BRAZIL SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 80. SAUDI ARABIA SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 81. SAUDI ARABIA SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 82. SAUDI ARABIA SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 83. SOUTH AFRICA SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 84. SOUTH AFRICA SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 85. SOUTH AFRICA SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 86. REST OF LAMEA SKIN ANTISEPTIC MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 87. REST OF LAMEA SKIN ANTISEPTIC MARKET, BY FORM, 2021-2031 ($MILLION)
    TABLE 88. REST OF LAMEA SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
    TABLE 89. CARDINAL HEALTH INC.: KEY EXECUTIVES
    TABLE 90. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
    TABLE 91. CARDINAL HEALTH INC.: PRODUCT SEGMENTS
    TABLE 92. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
    TABLE 93. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
    TABLE 94. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
    TABLE 95. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
    TABLE 96. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
    TABLE 97. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
    TABLE 98. B. BRAUN SE: KEY EXECUTIVES
    TABLE 99. B. BRAUN SE: COMPANY SNAPSHOT
    TABLE 100. B. BRAUN SE: PRODUCT SEGMENTS
    TABLE 101. B. BRAUN SE: PRODUCT PORTFOLIO
    TABLE 102. 3M COMPANY: KEY EXECUTIVES
    TABLE 103. 3M COMPANY: COMPANY SNAPSHOT
    TABLE 104. 3M COMPANY: PRODUCT SEGMENTS
    TABLE 105. 3M COMPANY: PRODUCT PORTFOLIO
    TABLE 106. ECOLAB INC.: KEY EXECUTIVES
    TABLE 107. ECOLAB INC.: COMPANY SNAPSHOT
    TABLE 108. ECOLAB INC.: PRODUCT SEGMENTS
    TABLE 109. ECOLAB INC.: PRODUCT PORTFOLIO
    TABLE 110. MOLNLYCKE HEALTH CARE AB: KEY EXECUTIVES
    TABLE 111. MOLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT
    TABLE 112. MOLNLYCKE HEALTH CARE AB: PRODUCT SEGMENTS
    TABLE 113. MOLNLYCKE HEALTH CARE AB: PRODUCT PORTFOLIO
    TABLE 114. XTTRIUM LABORATORIES: KEY EXECUTIVES
    TABLE 115. XTTRIUM LABORATORIES: COMPANY SNAPSHOT
    TABLE 116. XTTRIUM LABORATORIES: PRODUCT SEGMENTS
    TABLE 117. XTTRIUM LABORATORIES: PRODUCT PORTFOLIO
    TABLE 118. SIRMAXO CHEMICALS PVT.LTD.: KEY EXECUTIVES
    TABLE 119. SIRMAXO CHEMICALS PVT.LTD.: COMPANY SNAPSHOT
    TABLE 120. SIRMAXO CHEMICALS PVT.LTD.: PRODUCT SEGMENTS
    TABLE 121. SIRMAXO CHEMICALS PVT.LTD.: PRODUCT PORTFOLIO
    TABLE 122. SCHÜLKE & MAYR GMBH: KEY EXECUTIVES
    TABLE 123. SCHÜLKE & MAYR GMBH: COMPANY SNAPSHOT
    TABLE 124. SCHÜLKE & MAYR GMBH: PRODUCT SEGMENTS
    TABLE 125. SCHÜLKE & MAYR GMBH: PRODUCT PORTFOLIO
    TABLE 126. SCHÜLKE & MAYR GMBH: KEY STRATERGIES
    TABLE 127. PDI, INC.: KEY EXECUTIVES
    TABLE 128. PDI, INC.: COMPANY SNAPSHOT
    TABLE 129. PDI, INC.: PRODUCT SEGMENTS
    TABLE 130. PDI, INC.: PRODUCT PORTFOLIO
    TABLE 131. PDI, INC.: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 01. SKIN ANTISEPTIC MARKET, 2021-2031
    FIGURE 02. SEGMENTATION OF SKIN ANTISEPTIC MARKET, 2021-2031
    FIGURE 03. TOP INVESTMENT POCKETS IN SKIN ANTISEPTIC MARKET (2022-2031)
    FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
    FIGURE 05. LOW BARGAINING POWER OF BUYERS
    FIGURE 06. LOW THREAT OF SUBSTITUTES
    FIGURE 07. LOW THREAT OF NEW ENTRANTS
    FIGURE 08. LOW INTENSITY OF RIVALRY
    FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALSKIN ANTISEPTIC MARKET
    FIGURE 10. SKIN ANTISEPTIC MARKET, BY TYPE, 2021(%)
    FIGURE 11. COMPARATIVE SHARE ANALYSIS OF SKIN ANTISEPTIC MARKET FOR ALCOHOL, BY COUNTRY 2021-2031(%)
    FIGURE 12. COMPARATIVE SHARE ANALYSIS OF SKIN ANTISEPTIC MARKET FOR CHLORHEXIDINE, BY COUNTRY 2021-2031(%)
    FIGURE 13. COMPARATIVE SHARE ANALYSIS OF SKIN ANTISEPTIC MARKET FOR IODINE, BY COUNTRY 2021-2031(%)
    FIGURE 14. COMPARATIVE SHARE ANALYSIS OF SKIN ANTISEPTIC MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
    FIGURE 15. SKIN ANTISEPTIC MARKET, BY FORM, 2021(%)
    FIGURE 16. COMPARATIVE SHARE ANALYSIS OF SKIN ANTISEPTIC MARKET FOR SOLUTIONS, BY COUNTRY 2021-2031(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF SKIN ANTISEPTIC MARKET FOR CREAM, BY COUNTRY 2021-2031(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF SKIN ANTISEPTIC MARKET FOR SWAB STICKS, BY COUNTRY 2021-2031(%)
    FIGURE 19. COMPARATIVE SHARE ANALYSIS OF SKIN ANTISEPTIC MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
    FIGURE 20. SKIN ANTISEPTIC MARKET, BY DISTRIBUTION CHANNEL, 2021(%)
    FIGURE 21. COMPARATIVE SHARE ANALYSIS OF SKIN ANTISEPTIC MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY 2021-2031(%)
    FIGURE 22. COMPARATIVE SHARE ANALYSIS OF SKIN ANTISEPTIC MARKET FOR ONLINE PROVIDERS, BY COUNTRY 2021-2031(%)
    FIGURE 23. COMPARATIVE SHARE ANALYSIS OF SKIN ANTISEPTIC MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY 2021-2031(%)
    FIGURE 24. SKIN ANTISEPTIC MARKET BY REGION, 2021
    FIGURE 25. U.S. SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 26. CANADA SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 27. MEXICO SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 28. GERMANY SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 29. FRANCE SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 30. UK SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 31. ITALY SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 32. SPAIN SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 33. REST OF EUROPE SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 34. JAPAN SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 35. CHINA SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 36. AUSTRALIA SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 37. INDIA SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 38. SOUTH KOREA SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 39. REST OF ASIA-PACIFIC SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 40. BRAZIL SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 41. SAUDI ARABIA SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 42. SOUTH AFRICA SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 43. REST OF LAMEA SKIN ANTISEPTIC MARKET, 2021-2031 ($MILLION)
    FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 48. COMPETITIVE DASHBOARD
    FIGURE 49. COMPETITIVE HEATMAP: SKIN ANTISEPTIC MARKET
    FIGURE 50. TOP PLAYER POSITIONING, 2021
    FIGURE 51. CARDINAL HEALTH INC.: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 52. CARDINAL HEALTH INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 53. CARDINAL HEALTH INC.: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 54. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 55. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 56. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 57. B. BRAUN SE: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 58. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 59. B. BRAUN SE: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 60. 3M COMPANY: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 61. 3M COMPANY: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 62. 3M COMPANY: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 63. ECOLAB INC.: NET SALES, 2019-2021 ($MILLION)
    FIGURE 64. ECOLAB INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 65. ECOLAB INC.: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 66. MOLNLYCKE HEALTH CARE AB: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 67. MOLNLYCKE HEALTH CARE AB: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 68. MOLNLYCKE HEALTH CARE AB: REVENUE SHARE BY REGION, 2021 (%)

 
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The skin antiseptics are used to disinfect and clean the skin to reduce the risk of infection.

A. The base year is 2021 in skin antiseptic market.

A. The major factor that fuels the growth of the skin antiseptic market are increase in number of surgeries, surge in prevalence of hospital acquired infections (HAIs) and rise in awareness regarding infection control measures.

A. Infection leading application of Skin Antiseptic Market.

A. North America is the largest regional market for Skin Antiseptic.

A. The total market value of skin antiseptic market is $1484.28 million in 2021.

A. Top companies such as, Sirmaxo Chemicals Pvt.Ltd, 3M Company, Becton, Dickinson and Company and Cardinal Health Inc., held a high market position in 2021. These key players held a high market position owing to the strong geographical foothold in North America, Europe, Asia-Pacific, and LAMEA.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Skin Antiseptic Market

Start reading instantly.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers